SANUWAVE Health, Inc. financial data

Symbol
SNWV on Nasdaq
Location
3360 Martin Farm Rd, Suite 100, Suwanee, GA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 51.4 % +262%
Quick Ratio 14.3 % +243%
Debt-to-equity -372 % -154%
Return On Equity 59.1 % +7134%
Return On Assets -21.7 % -1138%
Operating Margin 16.6 % +23.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.58M shares +0.49%
Common Stock, Shares, Outstanding 8.58M shares +172%
Entity Public Float 13.6M USD +76.6%
Common Stock, Value, Issued 9K USD +200%
Weighted Average Number of Shares Outstanding, Basic 8.57M shares +169%
Weighted Average Number of Shares Outstanding, Diluted 9.14M shares +187%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 41.3M USD +40.9%
Revenue from Contract with Customer, Excluding Assessed Tax 41.1M USD +43.9%
Cost of Revenue 8.98M USD +12.8%
Research and Development Expense 901K USD +35.9%
Selling and Marketing Expense 7.14M USD +20.3%
General and Administrative Expense 16.6M USD +65.1%
Operating Income (Loss) 6.85M USD +74.2%
Income Tax Expense (Benefit) 4K USD +100%
Net Income (Loss) Attributable to Parent -7.04M USD -1711%
Earnings Per Share, Basic 0 USD/shares +93.8%
Earnings Per Share, Diluted -1 USD/shares +87.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.6M USD +195%
Accounts Receivable, after Allowance for Credit Loss, Current 4.62M USD +62.9%
Inventory, Net 6.81M USD +98.6%
Assets, Current 22.6M USD +129%
Property, Plant and Equipment, Net 1.99M USD +158%
Operating Lease, Right-of-Use Asset 431K USD
Intangible Assets, Net (Excluding Goodwill) 3.2M USD -18%
Goodwill 7.26M USD 0%
Assets 35.6M USD +63%
Accounts Payable, Current 3.99M USD -3.51%
Employee-related Liabilities, Current 1.04M USD -50.3%
Accrued Liabilities, Current 3.59M USD -31.6%
Contract with Customer, Liability, Current 252K USD +83.9%
Liabilities, Current 19.6M USD -76%
Contract with Customer, Liability, Noncurrent 322K USD -10.1%
Deferred Income Tax Liabilities, Net 28K USD 0%
Other Liabilities, Noncurrent 34K USD
Liabilities 38.5M USD -53.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 10K USD 0%
Retained Earnings (Accumulated Deficit) -246M USD -2.95%
Stockholders' Equity Attributable to Parent -2.93M USD +95.1%
Liabilities and Equity 35.6M USD +63%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.52M USD -238%
Net Cash Provided by (Used in) Financing Activities -57K USD -236%
Net Cash Provided by (Used in) Investing Activities -162K USD -42.1%
Common Stock, Shares Authorized 2.5B shares 0%
Common Stock, Shares, Issued 8.58M shares +172%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.74M USD -252%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.6M USD +195%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.12M USD +15.1%
Deferred Tax Assets, Valuation Allowance 45.6M USD -3.17%
Deferred Tax Assets, Gross 45.7M USD -3.3%
Operating Lease, Liability 1.09M USD
Payments to Acquire Property, Plant, and Equipment 162K USD +42.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.04M USD -2202%
Lessee, Operating Lease, Liability, to be Paid 1.41M USD
Operating Lease, Liability, Current 191K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 272K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 270K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 326K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 282K USD
Deferred Tax Assets, Operating Loss Carryforwards 41.5M USD -2.24%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 292K USD
Additional Paid in Capital 243M USD +36.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 209K USD +53.7%
Deferred Tax Assets, Net of Valuation Allowance 115K USD -36.1%
Share-based Payment Arrangement, Expense 1.4M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%